ALMS (Alumis) Change In Other Working Capital : $-1.86 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Alumis Change In Other Working Capital?

Alumis's Change In Other Working Capital for the quarter that ended in Mar. 2025 was $0.00 Mil. It means Alumis's Other Working Capital stayed the same from Dec. 2024 to Mar. 2025 .

Alumis's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was $-1.86 Mil. It means Alumis's Other Working Capital declined by $1.86 Mil from Dec. 2023 to Dec. 2024 .

Alumis Change In Other Working Capital Historical Data

The historical data trend for Alumis's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis Change In Other Working Capital Chart

Alumis Annual Data

Trend

Dec22

Dec23

Dec24

Change In Other Working Capital

-0.82

-0.14

-1.86

Alumis Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Other Working Capital	Get a 7-Day Free Trial					-0.50	-0.50	-0.47	-0.38	-

Alumis Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.86 Mil.

Alumis Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Alumis's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Alumis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

280 East Grand Avenue, South San Francisco, CA, USA, 94080

Website

https://www.alumis.com

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.